首页> 外文期刊>Indian Journal of Chemistry, Section B. Organic Including Medicinal >Synthesis of racemic and chiral Carvedilolstarting from corresponding5-(chloromethyl)oxazolidin-2-one
【24h】

Synthesis of racemic and chiral Carvedilolstarting from corresponding5-(chloromethyl)oxazolidin-2-one

机译:由相应的5-(氯甲基)恶唑烷-2-酮开始合成外消旋和手性卡维地洛

获取原文
获取原文并翻译 | 示例
           

摘要

The synthesis of racemic Carvedilol ((±)-l) has been achieved starting from 2-(chloromethyl) oxirane ((±)-2) in a four-step sequence. 5-(Chloromethyl) oxazolidin-2-one ((±)-3) and 5-((9H-carbazol-4-yloxy) methyl) oxazolidin-2-one ((±)-4) are intermediates. A similar sequence starting from (R)- or (S)-2-(chloromethyl)oxirane 2 give corresponding chiral 5-((9H-carbazol-4-yloxy)methyl) oxazolidin-2-one 4 followed by chiral Carvedilol 1. The synthetic sequence followed avoids the formation of impurity B (bis impurity). This approach can be useful for the preparation of pharmaceutically important moieties containing p-amino alcohols without formation of bis impurity.
机译:外消旋卡维地洛((±)-1)的合成已从2-(氯甲基)环氧乙烷((±)-2)分为四个步骤完成。 5-(氯甲基)恶唑烷-2-酮((±)-3)和5-(((9H-咔唑-4-基氧基)甲基)恶唑烷-2-酮((±)-4)是中间体。由(R)-或(S)-2-(氯甲基)环氧乙烷2起始的相似序列产生相应的手性5-(((9H-咔唑-4-基氧基)甲基)恶唑烷丁-2-酮4,然后是手性卡维地洛1。遵循的合成顺序避免了杂质B(双杂质)的形成。该方法可用于制备包含对氨基醇的药学上重要的部分,而不会形成双杂质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号